机制
2010+European Urology+Dynamic Progression of Overactive Bladder and and Urinary.pdf
387.05KB
Editorial 2+2016+International Journal of Urology+Propiverine increases urethral wall catecholam.pdf
38.42KB
2016+International Journal of Urology+Propiverine increases urethral wall catecholamine levels a.pdf
405.81KB
1  /  7
临床研究——NDO
ICS 2002 Poster+E-丙哌维林治疗神经源性膀胱 vs 奥昔布宁.pdf
12.58KB
ICS 2002 Abstract+E-丙哌维林治疗神经源性膀胱 vs 奥昔布宁.pdf
9.98KB
1999+E-丙哌维林 vs 安慰剂治疗NDO.pdf
150.27KB
1  /  2
临床研究——OAB
2018（英文）评估对既往抗胆碱能药物反应不良的盐酸丙哌维林的有效性.pdf
93.10KB
2017BJUI(英文)一项随机、双盲、活性对照临床试验的结果丙哌韦林缓释30mg治疗膀胱过度活动者.pdf
365.67KB
2011+Propiverine hydrochloride in Japanese patients with overactive bladder.pdf
354.30KB
2001（英文）丙哌维林治疗OAB.pdf
161.15KB
2016（英文）丙哌啶对年轻患者和年龄大于65岁的老年患者治疗OAB的疗效、耐受性和安全性的比较一项随机、双盲研究的事后分析.pdf
80.74KB
Efficacy and tolerability of propiverine hydrochloride extended-release compared with immediate-.pdf
235.95KB
madersbacher2001 15mg片剂.pdf
95.22KB
Urinary urgency outcomes after propiverine treatment for an overactive bladder.pdf
301.73KB
mazur1995.pdf
477.29KB
迈通诺III期临床研究.pdf
360.85KB
1  /  2
临床研究——安全性
2009+E-丙哌维林联合乙酰胆碱酯酶抑制剂（多奈哌齐）治疗痴呆伴OAB患者.pdf
161.67KB
2005+E-丙哌维林对神经系统疾病患者的认知功能没有影响.pdf
32.96KB
2011（英文）在成年OAB男性患者中，丙哌维林ER加或不加与最大尿流率相关的a受体阻滞剂的疗效一项12周、多中心、非介入研究的结果.pdf
227.26KB
1  /  4
临床研究——男科
Efficacy and safety of low-dose propiverine in patients with lower urinary tract symptoms.pdf
323.74KB
Long-term efficacy of a combination therapy with an anticholinergic agent and an α1-blocker for .pdf
568.75KB
Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms sugg.pdf
103.57KB
1  /  1
临床研究——尿失禁
1999年韩国的MUI.pdf
118.28KB
dorschner2000欧洲MUI.pdf
148.67KB
Efficacy and tolerability of propiverine hydrochloride extended-release compared with immediate-.pdf
235.95KB
1  /  3
临床研究——手术
2019（英文）盐酸丙哌维林治疗机器人或腹腔镜根治性前列腺切除术后尿失禁的疗效观察.pdf
93.09KB
peyronnet2018.pdf
1.03MB
2015（英文）一项随机、双盲、琥珀酸索利那新与安慰剂对照的4期多中心研究，评价机器人辅助根治性前列腺切除术后的尿控.pdf
308.22KB
1  /  2
流行病学
Impact of overactive bladder symptoms on employment, social interactions and emotional well-bein.pdf
106.43KB
2019-中国台湾韩国尿失禁横断面调查.pdf
983.99KB
The patient with an overactive bladder Symptoms and quality-of-life issues.pdf
1.44MB
1  /  2
指南共识
2017 AUA 手术治疗女性压力性尿失禁指南解读_李怀芳.pdf
182.62KB
2012 NICE指南：神经源性尿失禁.pdf
198.44KB
201 EAU指南：成人尿失禁.pdf
786.66KB
1  /  8
综述
2004+THE JOURNAL OF BIOLOGICAL CHEMISTRY+Overactive Bladder and Incontinence in the Absence of t.pdf
532.13KB
2009+Cell Calcium+Aberrant Ca2+ oscillations in smooth muscle cells from human overactive bladde.pdf
956.30KB
2007+Biol. Pharm. Bull+Pharmacological Characterization of a New Antimuscarinic Agent, Solifenac.pdf
263.33KB
1  /  8